On 5 18, the Ministry of Industry and Information Technology (MIIT) released the preliminary list of the second batch of key pilot platforms for cultivation, with 111 platforms selected across six major sectors. Among them生物制造领域独占8席Covering synthetic biology, intelligent biomanufacturing, green biomanufacturing, and AI-driven biomanufacturing, we have officially established the national-level pilot team for biomanufacturing.

These 8 platforms span天津、河北、江苏、湖南、广东、广西6 provinces and cities, covering strain construction, process development, pilot validation, regulatory filing, and intelligent manufacturing to form a complete closed loop from source innovation to scaled implementation, fundamentally solving the industry's critical bottleneck of "strong in the lab, weak in commercialization" for biomanufacturing.

[ 国家中试平台矩阵加速成型 ] .

The Ministry of Industry and Information Technology and the National Development and Reform Commission propose that by 2027, we aim to establish more than 20 pilot-scale capacity platforms for biomanufacturing, serve over 200 enterprises, incubate more than 400 products, and effectively support the transition from "small-scale testing" to "pilot-scale expansion" and finally to "industrial application" of innovation results.

中试平台It is an indispensable bridge connecting laboratory research to large-scale production, undertaking critical tasks such as process scale-up and technology validation. Pilot testing represents a crucial step in translating scientific achievements into commercial applications. As a key link in converting biotechnological innovations into industrial production, it serves as a vital pillar of the bio-manufacturing industry ecosystem.

The following 8 large-scale pilot platforms have been selected in the field of biomanufacturing:

https://www.miit.gov.cn/jgsj/kjs/jscx/zlpp/art/2026/art_a83e434fd5f043cd957964b68c243ac1.html

天津双雄：产业+科研，双轮驱动

Bloomage Biotechnology (Tianjin) Co., Ltd.

华熙生物是全球最大合成生物中试转化平台之一，4.4 万㎡空间、64 条中试线，总投资近 30 亿元，在工信部首批生物制造中试能力评选中，获评最高等级"Five-Star"，可一站式完成小试—中试—吨级试产，是玻尿酸等生物原料产业化 “超级工厂”。

Frontier Institute of Synthetic Biology, Tianjin University

This platform is powered by元英进院士领衔, a research team of 150+ people, was rated four stars in the Ministry of Industry and Information Technology's first pilot capacity evaluation for biomanufacturing, establishing a synthetic biology technology "基因合成与组装区-菌种构建与筛选区-发酵与工艺优化区-工艺放大与分离区-10 吨发酵平台”完整中试熟化链条。

河北・北化大秦皇岛院：绿色制造，京津冀转化标杆

北京化工大学秦皇岛环渤海生物产业研究院以生物制造为主要研究方向，涵盖生物能源、生物新材料、生物医药、环保、生物安全、农业生物技术in these fields, in 2025 year, the Research Institute was selected as one of the first "Biomanufacturing Pilot Capacity Construction Platforms" by the Ministry of Industry and Information Technology. Its green biomanufacturing industry pilot service and technology transfer base has been established with 8 sets of large-scale equipment clusters covering key links such as fermentation and separation/purification.

Jiangsu Suzhou Womei: Data-Driven, Smart Pilot Benchmark

Suzhou Wowei Biotechnology Co., Ltd. is a one-stop biomanufacturing solution provider driven by technical services and anchored in premium products, featuring "产品-工艺-工程-装备-耗材”一体化“智”造体系，与华熙并列Five-Starcontinuously injecting strong momentum into the high-quality development of the bio-manufacturing industry.

Hunan Dual-Platform Strategy: Leading Equipment Manufacturer + SME Services, Executed in Parallel

Chutian Pharmaceutical Equipment Co., Ltd.

As a company centered on pharmaceutical equipment,楚天科技 has developed a 50–5000L fully automated intelligent fermentation system that meets the cultivation needs of 50+ microorganisms. With deep integration of "equipment + process," we offer end-to-end engineering solutions ranging from bioreactor design to purification, serving over 200 projects annually.

湖南生物制造中试基地有限公司

The Hunan Biological Manufacturing Pilot Base is one of the first pilot bases for commercializing scientific and technological achievements in Hunan Province and a top-tier biological manufacturing pilot capacity platform announced by the Ministry of Industry and Information Technology of China. Equipped with 68 bioreactors, including ton-scale fermentation units, the base can simultaneously accommodate 4-5 pilot production lines and 2 mass production lines, providing酵、纯化、环保、能源Comprehensive craftsmanship support.

广东・慕恩生物：微生物菌种库，布局未来蛋白

As a company in China's microbial resource development and bio-manufacturing sector, MycoBio has deepened its focus onBio-agriculture, microbial protein, biomedicineIn high-end fields, the company holds over 36 million independent intellectual property rights.straincommercial microbial strain library, containing nearly 2 high-value strains identified and 213 strains with global and domestic invention patents filed.

The company is advancing the digitalization of its strain library, transforming physical strain resources into developable genomic data assets and establishing the library as critical national infrastructure for bio-manufacturing.

Guangxi Nanning Hanhe: AI + Bio-Manufacturing, Packed with Futuristic Vibes

Hanhe BioAI-Enabled Pilot Platform for BiomanufacturingLeveraging cutting-edge technologies such as artificial intelligence, synthetic biology, and fermentation engineering, we have built a full-chain intelligent pilot system spanning "AI-driven strain design," "smart fermentation control," "precision separation and purification," and "industrial-scale amplification." We provide process validation, small-batch trial production, and performance evaluation services to universities, research institutes, and industry partners, dedicated to bridging the final mile of technology commercialization.

From gene editing to smart fermentation, from microbial proteins to AI-driven design, biomanufacturing is reshaping the pharmaceutical, food, materials, and energy industries.

此次工信部 8 家生物制造中试 “国家队” 亮相，标志着我国打通实验室到产业的最后一公里，中国已站在这一变革的前沿，Trillion-dollar market size, dense layout of national-level pilot platforms, sustained policy support, and full-chain technology breakthroughs.These elements are collectively building a complete ecosystem that spans from the laboratory to the factory floor and from gene sequences to market-ready products, propelling China's transformation from a global leader in biomanufacturing into a world-class powerhouse.

Based on this,The 2026 BIO-TECH Manufacturing Industry Expo will be held grandly in Shanghai from 8/27-28.This exhibition is organized by Yimao Medical. Invited guests will be present on-site, including:2000+Attendee,150+ Speaker,50+Premium exhibitors, featuring "Exhibitions - Products - Conferences - PartnershipsFour core modules focused on "breakthroughs in fundamental research and cross-sector industrialization," establishing a benchmark event for the entire bio-manufacturing value chain.